$PLUR
Pluri Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Haifa
PLUR chart
What traders are saying about $PLUR
Latest postsPluri Inc. news
- Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments
Yahoo Finance ·
- Form 13D/A PLURI INC. For: 27 October By Investing.com
Investing.com India ·
- Form 4 Pluri Inc.: Alexandre Weinstein Manieu (Director, 10% Owner) For: 25 August
Investing.com Nigeria ·
- Cell Therapy Maker Pluri Takes 50% of ZEO to Crack Regenerative Medicine's $400K Cost Floor
Tech Times ·
- Israeli biotech firm to take 50% stake in Broward medical company
The Business Journals ·
- ZEO and Pluri Expand U.S. Regenerative Medicine and Longevity Platform
TradingView ·
- Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine
Yahoo Finance ·
- Pluri Inc. Estimates – NASDAQ:PLUR
TradingView ·
- Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company
Yahoo Finance ·
- Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity
Yahoo Finance ·
- Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor
Yahoo Finance ·
- Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment
Yahoo Finance ·
Pluri Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $1.0M | $1.3M | $326,000 | $287,000 |
| Net income | -$23.8M | -$22.6M | $21.3M | $28.9M |
| Diluted EPS | $-2.44 | $-3.56 | $-3.99 | $-6.24 |
| Total assets (year end) | – | $30.6M | $30.9M | $41.6M |
| Cash and equivalents (year end) | – | $4.7M | $7.2M | $5.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Pluri Inc.
- Ticker
- PLUR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Haifa
- Incorporated in
- NV
- Fiscal year end
- June 30
- SEC CIK
- 1158780
- Former names
- PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
Frequently asked questions
What exchange is Pluri Inc. listed on?
Pluri Inc. trades on the Nasdaq under the ticker symbol PLUR.
What industry is Pluri Inc. in?
Pluri Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Pluri Inc. headquartered?
Pluri Inc.'s business address on file with the SEC is in Haifa.
When does Pluri Inc.'s fiscal year end?
Pluri Inc.'s fiscal year ends on June 30.
How much revenue did Pluri Inc. report?
Pluri Inc. reported $1.0M in revenue for calendar year 2026, according to its SEC filings.